1 Calder PC, Dangour AD, Diekman C, Eilander A, Koletzko B, Meijer GW, Mozaffarian D, Niinikoski H, Osendarp SJ, Pietinen P, Schuit J, Uauy R (2010) Essential fats for future health. Eur J Clin Nutr. 64, Suppl. 4, S1–13.
2 Gebauer SK, Psota TL, Harris WS & Kris-Etherton PM (2006) n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83, Suppl. 6, 1526S–1535S.
3 Ward R (1990) Familial aggregation and genetic epidemiology of blood pressure. In Hypertension, Pathophysiology, Diagnosis and Management, pp. 81–100 [Laragh JH and Brenner BM, editors]. New York, NY: Raven Press.
4 Cook H & McMaster C (2002) Fatty acid desaturation and chain elongation in eukaryotes. In Biochemistry of Lipids, Lipoproteins and Membranes, 4th ed., pp. 181–204 [Vance DE, editor].
5 Biscione F, Pignalberi C, Totteri A, Messina F & Altamura G (2007) Cardiovascular effects of omega-3 free fatty acids. Curr Vasc Pharmacol. 5, 163–172.
6 Das U (2008) Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhytmic, anty-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 7, 37.
7 Cicero AF, Ertek S & Borghi C (2009) Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol. 7, 330–337.
8 Lahoz C, Alonso R, Ordovás JM, López-Farré A, de Oya M & Mata P (1997) Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. Eur J Clin Invest. 27, 780–787.
9 Fischer R, Dechend R, Qadri F, Markovic M, Feldt S, Herse F, Park JK, Gapelyuk A, Schwarz I, Zacharzowsky UB, Plehm R, Safak E, Heuser A, Schirdewan A, Luft FC, Schunck WH & Muller DN (2008) Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension. Hypertension 51, 540–546.
10 Das UN (2004) Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-beta to prevent human essential hypertension. Eur J Clin Nutr. 58, 195–203.
11 Engler MM, Engler MB, Pierson DM, Molteni LB & Molteni A (2003) Effects of docosahexaenoic acid on vascular pathology and reactivity in hypertension. Exp Biol Med (Maywood) 228, 299–307.
12 Mozaffarian D (2007) Fish, n-3 fatty acids, and cardiovascular haemodynamics. J Cardiovasc Med. 8, Suppl. 1, S23–S26.
13 Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL & Katan MB (2005) Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112, 1945–1952.
14 Mozaffarian D, Gottdiener JS & Siscovick DS (2006) Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol. 97, 216–222.
15 McLennan PL, Barnden LR, Bridle TM, Abeywardena MY & Charnock JS (1992) Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling. Cardiovasc Res. 26, 871–877.
16 Appel LJ, Miller ERIII, Seidler AJ & Whelton PK (1993) Does supplementation of diet with ‘fish oil’ reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 153, 1429–1438.
17 Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR & Kok FJ (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 20, 1493–1499.
18 Hartweg J, Farmer AJ, Holman RR & Neil HA (2007) Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia 50, 250–258.
19 Hartweg J, Farmera AJ, Holmanb R & Neil A (2009) Potential Impact of omega-3 Treatment on cardiovascular disease in type 2 diabetes. Curr Opin Lipidol 20, 30–38.
20 Rasmussen BM, Vessby B, Uusitupa M, Berglund L, Pedersen E, Riccardi G, Rivellese AA, Tapsell LL, Hermanen K, Kanwu study group, et al. (2006) Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy Subjects. Am J Clin Nutr. 83, 221–226.
21 Shah AP, Ichiuji AM, Han JK, Traina M, El-Bialy A, Meymandi SK & Wachsner RY (2007) Cardiovascular and endothelial effects of fish oil supplementation in healthy Volunteers. J Cardiovasc Pharmacol There. 12, 213–219.
22 Bao DQ, Mori T, Burke V, Puddey IB & Beilin LJ (1998) Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension 32, 710–717.
23 Ramel A, Pumberger C, Martinez AJ, Kiely M, Bandarra NM & Thorsdottir I (2009) Cardiovascular Risk Factors in young, overweight, and obese European adults and associations with physical activity and omega-3 index. Nutr Res. 29, 305–312.
24 Gulseth HL, Gjelstad IM, Tierney BC, Shaw DI, Helal O, Hees AM, Delgado J, Leszczynska-Golabek I, Karlström B, Lovegrove J, Defoort C, Blaak EE, Lopez-Miranda J, Dembinska-Kiec A, Risérus U, Roche HM, Birkeland KI & Br Drevon CA (2010) Dietary fat and blood pressure modifications in subjects with the metabolic syndrome in the dietary intervention LIPGENE study. J Nutr. 104, 160–163.
25 Cicero AF, Derosa G, Di Gregorio V, Bove M, Gaddi AV & Borghi C (2010) Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. Clin Exp Hypertens 32, 137–144.
26 Micallef MA & Garg ML (2009) Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis. 204, 476–482.
27 Murphy KJ, Meyer BJ, Mori TA, Burke V, Mansour J, Patch CS, Tapsell LC, Noakes M, Clifton PA, Barden A, Puddey IB, Beilin LJ & Howe PR (2007) Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular Risk factors. Br J Nutr. 97, 749–757.
28 Theobald Middleaged HE, Goodall AH, Sattar N, Talbot DC, Chowienczyk PJ & Sanders TA (2007) Low-dose docosahexaenoic acid lowers diastolic blood pressure in men and women. J Nutr 137, 973–978.
29 Sanders TA, Gleason K, Griffin B & Miller GJ (2006) Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6n-3) and docosapentaenoic acid (22:5n-6) on Cardiovascular Risk Factors in Healthy Men and Women. Br J Nutr 95, 525–531.
30 Mori TA, Bao DQ, Burke V, Puddey IB & Beilin LJ (1999) Docosahexaenoic acid but not eicosapentaenoic Acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 34, 253–260.
31 Vernaglione L, Cristofano C & Chimienti S (2008) Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study. J Nephrol. 21, 99–105.